- Home
- /
- GHK-Cu 50mg
GHK-Cu 50mg
Certificate of Analysis
HPLC + Mass Spectrometry included with order
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. Its concentration declines with age — from approximately 200ng/ml at age 20 to 80ng/ml by age 60 — making it a significant area of ageing research.
Published studies have investigated GHK-Cu across wound healing, skin remodelling, collagen synthesis, anti-inflammatory signalling, and gene expression modulation. Research indicates that GHK-Cu may influence the expression of over 4,000 human genes, with a significant proportion involved in tissue repair and regeneration.
Kyrolab stocks GHK-Cu in injectable-grade format at premium dosages exclusive to our UK supplier. The 50mg per vial format represents exceptional research value and is independently verified at near-perfect purity.
Independently Verified Purity: 99.715%
Tested by Janoshik Analytical (Prague) — Task #95742, 31 December 2025.
Actual content: 56.09mg per vial (12% overfilled vs stated 50mg dose).
This is a 50mg PER VIAL product.
Verification: janoshik.com/verify — Key:
3XHENDG5T2AJ
Specifications
| Molecular Weight | 403.93 g/mol |
| Molecular Formula | C14H24N6O4Cu |
| CAS | 49557-75-7 |
| Sequence | Gly-His-Lys:Cu(II) |
| Dose | 50mg per vial |
| Appearance | Blue lyophilised powder |
| Storage | 2-8°C, protect from light |
This product is sold strictly for in-vitro research and laboratory purposes. Not for human or animal consumption. Not evaluated by the MHRA or FDA. Must be 18+ to purchase. By purchasing, you agree to our Research Disclaimer and Terms of Service.
| Catalogue Number | KYR-GHKCU50MG |
| Compound Name | GHK-Cu 50mg |